Published Date: 16 Mar 2023
In Part 1 of the Obesity Series, Katherine H. Saunders, MD, DABOM discusses ways to treat childhood obesity, including the benefits of FDA-approved drugs and Intellihealth.
Read Full News1.
New imaging solution could help improve survival for patients with recurring prostate cancer
2.
In MDS at Lower Risk, Novel Therapy Diminished Transfusion Dependency.
3.
What Could This Exploratory 5-Year Survival Data in Adjuvant NSCLC Treatment Mean?
4.
Screening for prostate cancer: is it time to give up digital rectal examination?
5.
Scientists hail the cervical cancer treatment as the most remarkable breakthrough in 20 years.
1.
Mechanistic Depth and Clinical Impact of Rusfertide, Onyvide, IV Avastin, and Pemfexy
2.
Liquid Biopsy in Oncology: Innovations in Cancer Detection, Monitoring, and Clinical Use
3.
Uncovering the Hidden Symptoms of Parathyroid Cancer in Women
4.
The Statistical Evolution of Cancer Staging and Its Precision Impact on Prognosis and Therapy in Cancer Staging 2025
5.
Iron Deficiency Anemia: Challenges in Diagnosis and Treatment
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
1.
Post Progression Approaches After First-line Third-Generaion ALK Inhibitors
2.
Navigating the Complexities of Ph Negative ALL - Part V
3.
First Line Combination Therapy- The Overall Survival Data in NSCLC Patients
4.
The Landscape of First-Line Treatment for Urothelial Carcinoma- The Conclusion
5.
Understanding the Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- PALOMA 2 Study.
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation